Cargando…

Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitors

OBJECTIVES: Skeletal myopathies are highly morbid, and in rare cases even fatal, immune-related adverse events (irAE) associated with immune checkpoint inhibitors (ICI). Skeletal myopathies are also a recognized statin-associated side effect. It is unknown whether concurrent use of statins and ICIs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drobni, Zsofia D, Murphy, Sean P, Alvi, Raza M, Lee, Charlotte, Gong, Jingyi, Mosarla, Ramya C, Rambarat, Paula K, Hartmann, Sarah B, Gilman, Hannah K, Zubiri, Leyre, Raghu, Vineet K, Sullivan, Ryan J, Zafar, Amna, Zlotoff, Daniel A, Sise, Meghan E, Guidon, Amanda C, Reynolds, Kerry L, Dougan, Michael, Neilan, Tomas G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Immune-related Adverse Events in Cancer Immunotherapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444991/ https://www.ncbi.nlm.nih.gov/pubmed/34541581 http://dx.doi.org/10.1093/immadv/ltab014

Ejemplares similares

Pericardial disease in patients treated with immune checkpoint inhibitors
por: Gong, Jingyi, et al.
Publicado: (2021)

Diagnosis and Management of Hepatitis in Patients on Checkpoint Blockade
por: Reynolds, Kerry, et al.
Publicado: (2018)

Hematologic Complications of Immune Checkpoint Inhibitors
por: Davis, Elizabeth J., et al.
Publicado: (2019)

Late‐Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor–Induced Raynaud's‐Like Phenomenon
por: Khan, Shaheen, et al.
Publicado: (2020)

A Case of Nivolumab‐Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein‐1/Programmed Death Ligand‐1 Inhibitors and Recommendations for Diagnosis and Management
por: Lopez, Adriana T., et al.
Publicado: (2018)

Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After Immunotherapy
por: Lee, Charlotte, et al.
Publicado: (2022)

Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor–Associated Myocarditis
por: Drobni, Zsofia D., et al.
Publicado: (2020)

Onset of Transient Sadness Following the Concomitant Use of a Triptan and Selective Serotonin Reuptake Inhibitor/Serotonin Norepinephrine Reuptake Inhibitors Therapy: A Case Report
por: Meng, Yuki, et al.
Publicado: (2021)

The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil–Associated Coronary Vasospasm
por: Zafar, Amna, et al.
Publicado: (2021)

Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors
por: Drobni, Zsofia D., et al.
Publicado: (2022)

Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
por: Zubiri, Leyre, et al.
Publicado: (2021)

Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer
por: Drobni, Zsofia Dora, et al.
Publicado: (2023)

Diagnostic utility of CT for suspected immune checkpoint inhibitor enterocolitis
por: Durbin, Sienna M, et al.
Publicado: (2020)

Electrocardiographic features of immune checkpoint inhibitor associated myocarditis
por: Zlotoff, Daniel A, et al.
Publicado: (2021)

Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study
por: Tiu, Bruce C, et al.
Publicado: (2022)

The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm
por: Zafar, Amna, et al.
Publicado: (2022)

Immune‐Related Adverse Events in the Setting of PD‐1/L1 Inhibitor Combination Therapy
por: Zubiri, Leyre, et al.
Publicado: (2019)

Imatinib-induced pleural effusion: A case report
por: Banka, R, et al.
Publicado: (2017)

Lansoprazole-Induced Thrombocytopenia in a Critically Ill Patient: A Case Report
por: Saad, Mohamed, et al.
Publicado: (2019)

Lenalidomide-induced focal myocarditis mimicking acute ST segment elevation myocardial infarction
por: Tse, Yiu-Hei, et al.
Publicado: (2021)

Unexpected bradycardia after a first dose of doxazosin
por: Pigot, James Edward, et al.
Publicado: (2022)

SPLIT-DOSING OF COVID-19 VACCINES IS SAFE AND PROVIDES NON-INFERIOR ANTIBODY RESPONSIVENESS TO CONVENTIONAL VACCINE DOSING
por: Musa, A., et al.
Publicado: (2022)

Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data
por: Reynolds, Kerry L, et al.
Publicado: (2021)

T057: Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume
por: Lynch, Ryan C., et al.
Publicado: (2022)

A case of probable bemiparin-induced HIT type II managed with low-dose fondaparinux
por: Koufakis, T, et al.
Publicado: (2015)

Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA
por: Kalinich, Mark, et al.
Publicado: (2021)

IRF5 Promotes Influenza Virus-Induced Inflammatory Responses in Human Induced Pluripotent Stem Cell-Derived Myeloid Cells and Murine Models
por: Forbester, Jessica L., et al.
Publicado: (2020)

Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy
por: Schina, Aimilia, et al.
Publicado: (2023)

117. COVID-19 Youth Impact Survey: The effects of COVID-19 on Youth Experiencing Homelessness
por: Auerswald, Colette, et al.
Publicado: (2022)

116. Conducting an Online Survey of Youth Experiencing Homelessness During the COVID-19 Pandemic Employing Youth Participatory Action Research: Lessons Learned
por: Auerswald, Colette, et al.
Publicado: (2022)

Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis
por: Sise, Meghan E, et al.
Publicado: (2023)

Welcoming words
por: Garcia Tello, Pablo
Publicado: (2017)

Challenge Based Innovation Introduction
por: Bragós, Ramon, et al.
Publicado: (2017)

Team Wu: EDUCATION AND ENTREPRENEURSHIP TO EMPOWER WOMEN AND YOUTH
por: Kandipati, Sindhura, et al.
Publicado: (2017)

Team Geiger: OPERATIONAL METHODS FOR RADIATION INSPECTION
por: Kulaviseyed Mohamed Buhari, Ziaulhaq Soofi, et al.
Publicado: (2017)

Team Sutherland: VIRTUAL REALITY TRAINING FOR EMERGENCY SANITARY MISSIONS
por: Gombau, Xavier, et al.
Publicado: (2017)

Team Margulis: REDESIGNING KNOWLEDGE SHARING
por: Eline, Thomas, et al.
Publicado: (2017)

Team Carson: PUBLIC HEALTH AND ENVIRONMENT
por: de Rodrigo Navarro, Ruben, et al.
Publicado: (2017)

Public thesis defense: "Experiment and machine protection from fast losses caused by crab cavities in the High Luminosity LHC"
por: Santamaria Garcia, Andrea
Publicado: (2018)

Questions & Answers
por: CERN. Geneva
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_14r2c6gks4tdrm70gno8mmn8lm